#gene mutation

People with mutations that lead to excessively long chromosome tips, or telomeres, may be at increased risk for a range of cancers.

Understanding cancer DNA evolution is key to developing targeted therapies.

CU Cancer Center researchers spotlight how p53, the most frequently mutated tumor suppressor gene, can be activated against cancer cells.

His cancer has returned, but Dann Wonser gets into a clinical trial for a med proven effective for his mutation (EGFR exon 19).

Watch these videos to learn how the Prostate Cancer Promise registry aims to identify hereditary DNA mutations.

Promising research shows that marking the mutated KRAS protein of cancer cells can signal the immune system to destroy that cancer.

Is DNA fate? Are cell mutations really the cause of cancer? A Fred Hutch skin cancer and stem cell scientist poses other possibilities.

The combination of target drugs Tafinlar-Mekinist is approved for nearly any type of advanced solid tumor that has the BRAF gene mutation.

Researchers are developing new treatments for people with HER2-positive breast cancer.

Artificial intelligence and machine learning can help identify genetic changes that lead to cancer—and which treatments work best.

In a small trial, Jemperli led to complete remission in people with a biomarker for deficient DNA repair.

Ivosidenib (Tibsovo) plus chemotherapy may soon be an option for those with leukemia that has an IDH1 mutation.

Embryos in the womb can get gene mutations that lead to cancer in adulthood.

Oncogenic mutations are common, and vary in different tissue types, before people develop cancer.

A new study provides a mechanistic link between red meat consumption and colorectal cancer development.

Mutations can affect how viruses behave and how well drugs and vaccines work.